Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,512.38 -3.89 -0.03%
TOPIX 1,171.40 -1.97 -0.17%
HANG SENG 22,760.24 64.23 0.28%

Syngenta share repurchases: end-year report



                 Syngenta share repurchases: end-year report

PR Newswire

BASEL, Switzerland, Jan. 3, 2013

BASEL, Switzerland, Jan. 3, 2013 /PRNewswire/ -- Syngenta has completed the
share repurchases authorized by the Annual General Meeting on April 22, 2008.
The authorization allowed for the repurchase of up to 10 percent of
outstanding shares.

In total, 1,487,200 shares were repurchased between March 8, 2010 and
end December 2012 through a second trading line on the SIX Swiss Exchange.
This represents 1.5 percent of outstanding shares at the time of authorization
and a total amount of $402 million.

In accordance with motions passed at the Annual General Meetings on April 19,
2011 and April 24, 2012 a total of 1,473,700 shares have been canceled. The
company plans to propose the cancellation of the remaining 13,500 shares at a
subsequent Annual General Meeting.

Syngenta is one of the world's leading companies with more than 26,000
employees in over 90 countries dedicated to our purpose: Bringing plant
potential to life. Through world-class science, global reach and commitment to
our customers we help to increase crop productivity, protect the environment
and improve health and quality of life. For more information about us please
go to www.syngenta.com.

Cautionary Statement Regarding Forward-Looking Statements
This document contains forward-looking statements, which can be identified by
terminology such as 'expect', 'would', 'will', 'potential', 'plans',
'prospects', 'estimated', 'aiming', 'on track' and similar expressions. Such
statements may be subject to risks and uncertainties that could cause the
actual results to differ materially from these statements. We refer you to
Syngenta's publicly available filings with the U.S. Securities and Exchange
Commission for information about these and other risks and uncertainties.
Syngenta assumes no obligation to update forward-looking statements to reflect
actual results, changed assumptions or other factors. This document does not
constitute, or form part of, any offer or invitation to sell or issue, or any
solicitation of any offer, to purchase or subscribe for any ordinary shares in
Syngenta AG, or Syngenta ADSs, nor shall it form the basis of, or be relied on
in connection with, any contract therefor.

Syngenta International AG  Media contacts:         Analyst/Investor contacts:
Media Office               Paul Barrett            Jennifer Gough
CH-4002 Basel              Switzerland  +41 61 323 Switzerland  +41 61 323
                           2323                    5059
Switzerland                                        USA              +1 202 737
                                                   6521
Tel:  +41 61 323 2323
Fax: +41 61 323 2424       Daniel Braxton          Lars Oestergaard
                           Switzerland  +41 61 323 Switzerland  +41 61 323
                           2323                    6793
www.syngenta.com                                   USA              +1 202 737
                                                   6520

SOURCE Syngenta

Website: http://www.syngenta.com
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement